Skip to main content

Pharmaceutical Health Outcomes and Policy

Ph.D. Degree Program

Note to Applicants: The application deadline for Fall 2018 semester admission is January 10, 2018Go to Admissions page.

The Pharmaceutical Health Outcomes and Policy (PHOP) doctoral degree program at the University of Houston College of Pharmacy offers a learning and research environment that combines the collaborative opportunities of the Texas Medical Center’s world-class healthcare and scientific community with the academic resources and award-winning faculty at Houston’s only Carnegie Institute-designated Tier One public research university.

photo of PHOP students and instructor

Pharmaceutical Health Outcomes and Policy consists of pharmaceutical practice and policy research, a multidisciplinary field that examines cost, access, and quality of pharmaceutical care from clinical, sociobehavioral, economic, organizational and technological perspectives.

Traditional and innovative areas of pharmaceutical health outcomes research include pharmacoepidemiology, pharmacoeconomics, comparative effectiveness research, patient-centered outcomes research, and translational research.

The Ph.D. in Pharmaceutical Health Outcomes and Policy requires the completion of a minimum number of 70 credit hours

Almost all of our students (international and domestic) are awarded stipends from Research or Teaching Assistantships, and are reimbursed for all tuition and fees. Please see the Financial Aid section for more details.

Download Ph.D. in Pharmaceutical Health Outcomes and Policy program flier (.pdf)

For additional details about the program, visit the PHOP PhD page here.

For program admissions information, visit the PhD Graduate Admissions page here

Recent PHOP News

2017 Headlines

UHCOP Team Wins Historic Repeat Win in ISPOR Student Research Competition

PHOP Student, Faculty and Alumni Presentations at ISPOR 2017 Boston (.pdf)

Research Presentations Recognized at Houston Medication Safety Symposium 

April 28 Houston Medication Safety Symposium Tackles Opioid Abuse, High Risk Drugs in Older Adults

Study of Prescription Drug Monitoring Program Suggests Abuse Going Underreported

Research Team Earns $207K Grant for Study of Anticoagulants, Antiarrhythmia Drugs in Afib

PHOP Alumna Ferries Wins Humana's Jim Bloem Award

2016 Headlines

PHOP Research on Parental Stress Among ISPOR European Congress Poster Finalists

Inside Outcomes PHOP Newsletter Summer 2016 (.pdf)

Sanofi Backs Fleming's Prescriber Webinar to Boost Statin Guidelines Adoption, Adherence

Regeneron Funds Abughosh Study on Motivational Interviewing, Statin Adherence

Graduate Students Land Internships in Pharmaceutical, Consulting Sectors

PHOP Team Takes Research Competition Trophy at ISPOR International Meeting

4 PHOP Projects Among ISPOR Research Posters Finalists

PHOP Presentations at ISPOR Interational Meeting 2016 (.pdf)

PHOP Doctoral Candidate Inducted into Phi Kappa Phi Honor Society

Project on COPD Patients in Medicare Gap Strikes Gold at AMCP Meeting

Aparasu Tapped for Fulbright Specialist Roster 

(PDF links requires Adobe Reader; click here for free download.)